We tested the hypothesis that insulin-like growth factor-I (IGF-I) stimulates ovarian androgen production by increasing theca-interstitial cell luteinizing hormone (LH) binding affinity and/or binding capacity. We then investigated the role of transcriptional and translational events in mediating these actions of IGF-I.
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lates DNA synthesis and cellular differentiation in a variety of tissues (2) . Recent studies suggest that IGF-I plays a role in ovarian theca-interstitial cell function (3) (4) (5) . These cells, under stimulation by luteinizing hormone (LH), are responsible for the synthesis of the androgenic precursors required for estrogen production by the ovary (6, 7) . Studies using primary cultures of rat ovarian theca-interstitial cells indicate that these cells contain IGF-I receptors and respond to IGF-I with an increase in androgen synthesis; treatment with IGF-I in concentrations of 1-100 ng/ml potentiates the LH-induced stimulation of androgen output 5-to 30-fold above levels seen with LH alone (3) (4) (5) . Insulin, by interacting with its own or IGF-I receptors, can mimic the effects of IGF-I on the ovary, stimulating androgen production to values observed with IGF-I (3, 5, (8) (9) (10) (11) .
These studies have provided insight into the role of IGF-I and insulin in the pathophysiology of polycystic ovary syndrome, a clinical condition characterized by theca-interstitial cell hyperplasia, hyperandrogenism, and virilization (12) . Polycystic ovary syndrome has been described in acromegaly and is frequently encountered in insulin resistant syndromes that are accompanied by hyperinsulinemia (10, [12] [13] [14] [15] . It appears likely that in these conditions the elevated IGF-I or insulin concentrations are interacting with IGF-I receptors and stimulating theca-interstitial cell hyperplasia and increased androgen production (10, 12, 15) .
The mechanisms by which IGF-I potentiates the LH-induced stimulation of androgen synthesis are not clear. In the present study, we tested the hypothesis that IGF-I increases androgen synthesis in rat ovarian theca-interstitial cells by increasing LH receptor number and/or binding affinity. Having observed this to be the case, we then investigated the role of transcriptional and translational events in mediating the effects of IGF-I on androgen synthesis and LH binding. Magoffin and Erickson (6) . Briefly, ovaries from 20-d-old hypophysectomized female Sprague-Dawley rats were removed on the fourth postoperative day, minced, and theca-interstitial cells dispersed with collagenase and deoxyribonuclease as described previously (3, 6) . Approximately 1-2 x 106 cells were obtained from each ovary and 90% were determined to be viable by trypan blue dye exclusion. The dispersed cells were cultured on 6-well plates at a concentration of -I X 10 cells/ml in serum-free McCoy's medium supplemented with 100 U/ml penicillin, 100 ig/ml streptomycin, and 2 mM L-glutamine in 5% CO2 at 370C. Dispersed cells in triplicate wells were preincubated with and without the desired hormones by culturing for 48 h in serum-free medium in the absence (control) and in the presence of increasing concentrations of LH and/or IGF-I. Binding studies were performed after 48 h of preincubation, once the cells had become adherent to the polystyrene plates. In all cases, the medium was removed before performing the binding assays and stored at -20'C until assayed for steroids. In all experiments an aliquot of the cellular material was saved for determination of the DNA concentration, as described previously (3) .
Androsterone assay. The supernatant medium from theca-interstitial cells preincubated with the desired hormones and/or inhibitors, as described above, was removed and stored at -20'C until assayed for steroids. The androsterone concentration in these samples was quantitated by RIA after benzene extraction, as described previously (3) .
Radiolabeling ofLH. LH was radiolabeled to a specific activity of -100-200 ;Ci/jig as described previously (16). Briefly, highly purified LH 1-3 was radioiodinated with 125I using the chloramine T technique (17) and the radioactive protein fraction separated from inorganic iodide on a 0.9 X 10cm Sephadex G-50 column (Pharmacia Fine Chemicals, Piscataway, NJ (6), with modifications. Briefly, monolayer cultures ofovarian theca-interstitial cells preincubated with and without added hormones were washed with medium 199 containing 0.1% BSA and incubated in the same medium with -10 pM radiolabeled LH in the presence and absence of increasing concentrations of unlabeled hormone. After incubation, the cells were washed with ice-cold PBS, solubilized with 0.5 N NaOH, and an aliquot removed for determination of the bound radioactivity. Total binding was defined as the radioactivity bound to monolayers in the absence of unlabeled LH. Nonspecific binding was determined by measuring the bound radioactivity in the presence of 1 jig/ml unlabeled LH.
Competitive binding data were analyzed as described previously (3) by a modification ofthe method of Marquardt (18) and by the method of Scatchard ( 19) to determine the dissociation constant and the binding capacity. For these calculations, it is assumed that the LH preparation is pure and has full biological activity (i.e., 1 preincubated for 48 h in the presence of 1 or 10 ng/ml LH. Analysis of the binding data from cells preincubated with 1 ng/ml LH revealed a decrease in the binding capacity with no change in the Kd, as shown in Fig. 1 (inset) and in Table I . The binding of radiolabeled LH after preincubation with 10 ng/ml LH was too low to allow appropriate analysis of the competitive binding data.
When rat ovarian theca-interstitial cells were preincubated with IGF-I, an increase in radiolabeled LH binding was observed. Increasing concentrations of IGF-I progressively increased radiolabeled LH binding to theca-interstitial cells; 1, 10, and 100 ng/ml IGF-I increased the percent maximal LH bound to 121, 144, and 191% of control values, respectively. Because 100 ng/ml IGF-I increased LH binding maximally, while remaining within the physiological range, this dose of IGF-I was selected for further studies. As shown in Fig. 2 , preincubation with 100 ng/ml IGF-I increased the maximal specific binding of LH, both in cells cultured in the absence and presence ofeither 1 or 10 ng/ml LH. As can be seen in Fig.  3 , theca-interstitial cells cultured with 100 ng/ml IGF-I bound more radiolabeled LH than control cells. Scatchard analysis of the binding data revealed that preincubation with IGF-I caused a nearly twofold increase in the LH binding capacity, as shown in Fig. 3 (inset) and in Table I . Likewise, competitive binding studies performed with theca-interstitial cell monolayers preincubated with LH alone (1 ng/ml) or a combination of LH and 100 ng/ml IGF-I, revealed that cells cultured with a combination of LH and IGF-I bound more radiolabeled LH than cells cultured with LH alone (Fig. 4) . Scatchard analysis Fig. 4 (inset) and in Table I . Androsterone levels were quantitated by RIA in the supernatant medium of theca-interstitial cells in order to determine if the change in LH binding in response to treatment with LH (downregulation) or IGF-I (upregulation) was associated with a comparable change in androgen production. As seen in Fig.  5 , incubation of theca-interstitial cells with 1 ng/ml LH increased androsterone concentrations nearly fourfold above control values (1 17±17 vs. 31±6.5 ng/ml, respectively, P LH Concentration (nglml) Figure 5 . Effect of incubation of theca-interstitial cells with increasing doses of LH, with (hatched bars) and without (black bars) 100 ng/ml IGF-I, on androsterone production. Cells were cultured in the absence and presence of LH and/or IGF-I as described in the text. After 48 h, the medium was removed and the androsterone concentration determined by RIA. Shown are mean ± SEM from three separate determinations.
< 0.05). On the other hand, androsterone synthesis by thecainterstitial cells cultured with 10 ng/ml LH were lower than those observed with 1 ng/ml LH (86±6.5 vs. 117±17 ng/ml, respectively). Incubation of cells with 100 ng/ml IGF-I, in the presence of both 1 and 10 ng/ml LH, increased androsterone levels to 186±39 and 124±31 ng/ml, respectively, 59 and 44% above values obtained with the corresponding doses of LH alone. Thus, the increase in androsterone production induced by IGF-I appeared to be proportional to the upregulation of LH binding capacity stimulated by this peptide. The effect of DRB and CHX on IGF-I-mediated theca-interstitial cell LH binding capacity and androsterone synthesis were examined in order to determine if the enhancement of LH binding and the increase in androgen production stimulated by IGF-I were mediated by transcriptional and/or translational events. In experiments similar to those described above theca-interstitial cells were preincubated with 100 ng/ml IGF-I with increasing concentrations of DRB or CHX and LH binding and androsterone production subsequently determined. As shown in 6 . Effect of DRB on IGF-I-mediated enhancement of LH binding and androsterone production in theca-interstitial cell cultures. Theca-interstitial cells were preincubated for 24 h with 100 ng/ml IGF-I, in combination with increasing concentrations of DRB, as described in the text. The medium was subsequently removed, the androsterone concentration quantitated by RIA, and LH binding studies then performed. Shown is the mean ± SEM percent versus control from three separate determinations. enhancement of LH binding mediated by IGF-I. However, the stimulation of androsterone synthesis under these conditions was not affected. On the other hand, treatment with increasing concentrations ofCHX inhibited both the enhancement ofLH binding and the stimulation of androsterone synthesis mediated by IGF-I, as shown in Fig. 7 . At all doses tested, CHX decreased the maximal specific LH binding and stimulation of androsterone synthesis induced by IGF-I to control values. These observations could not be attributed to a difference in cell survival or cell number, since DNA measurements were no different with these various treatments (data not shown).
Discussion
Recent reports have indicated that the ovarian androgen producing cell represents a target for the actions of IGF-I (3-5). In cultured rat ovarian theca-interstitial cells, IGF-I potentiates the LH-induced stimulation of androgen synthesis in a potent and dose-dependent manner, an effect which becomes significant at 96 h of culture (3) . In the present report, we present data supporting the concept that the potentiation of androgen synthesis by IGF-I occurs, at least in part, as the result of an induction of LH receptors on these cells.
We observed that radiolabeled LH bound to a saturable, high affinity specific binding site on theca-interstitial cells with a binding affinity of 0.05 nM and a binding capacity of -1.9 fmol/ 106 cultured cells. Similar results have been reported previously by Magoffin and Erickson (6) and Erickson et al. (7) . The possibility that LH bound to the granulosa cells present in the rat ovarian cell monolayers appears unlikely since granulosa cells from hypophysectomized rats lack LH receptors unless stimulated with follicle-stimulating hormone (FSH) (23, 24) . Likewise, since both our results and results from comparable studies (3, 4) have shown that treatment with LH or IGF-I does not lead to an increase in the DNA content of the theca-interstitial-cell monolayers, it is unlikely that the results obtained reflect changes in cell survival or number rather than changes in LH binding sites.
Preincubation with LH produced a dose-dependent decrease in the LH binding capacity of rat ovarian theca-interstitial cells, suggesting that LH treatment produces downregula- (31) . In Leydig cells, prolonged exposure to higher concentrations of LH results in impaired androgen production and is probably the case in theca too, as a result of a decrease in the activity of stromal steroidogenic enzymes, as reviewed by Richards and Hedin (27) .
We observed that treatment with both DRB and CHX inhibited the effect of IGF-I on the enhancement of LH binding. Thus, inhibition of both transcription and translation, respectively, inhibited the IGF-I-induced increase in LH binding capacity. These results suggest that the increase in LH binding capacity stimulated by IGF-I is mediated by transcriptional events, possibly the result of a direct effect of IGF-I on LH receptor gene expression or, alternatively, the result of an effect of IGF-I on the expression of regulatory proteins affecting LH binding capacity. On the other hand, inhibition of transcription had no effect on the increase in androsterone production stimulated by IGF-I while translational inhibition blunted this biological response. These results suggest that the effects of IGF-I on androgen production by theca-interstitial cells are in part mediated by a direct effect of this peptide on the translational processes required for androgen biosynthesis. This effect of IGF-I could involve synthesis of either the steroidogenic enzymes or the synthesis of regulatory proteins that modulate steroidogenic enzyme activity. /
